Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
how much is this company worth? 30 million or 140 Million? If 140 million we should run to a 1.10. CCTL buy some stock back.
Get ready of them posing a new profit with a new successful direction. News is coming. Call it10 million net!! $$1and !!
Over 63 million doses of COVID-19 vaccines were administered in the United States from December 14, 2020, through February 21, 2021. During this time, VAERS received 1,099 reports of death among people who received a COVID-19 vaccine. CDC and FDA will continue to investigate reports of adverse events, including deaths, reported to VAERS.
https://www.cdc.gov/coronavirus/2019-ncov/vaccines/safety/adverse-events.html
Two deals in a month on with JV Minerco, Inc, and JV PsychDev Inc. I feel like two more coming very soon. Big run coming to .40.
short covering reddit is coming to save DEWM. A big run .10 have fun.
As we all wait for the Data Safety and Monitoring Board to release a statement, I thought it would be a good idea to explain the findings of my research into the technical aspects of how Bucillamine might, or might not, work as a therapy for COVID-19.
I estimate the share price would be worth around 20 cents if the clinical trial results are unfavorable, and around $2-$5 if the results are favorable. A lot is riding, near term, on a favorable outcome.
Anyone who has been following this trial will know that the main concern is not safety, since the dosages of Bucillamine being used have been safe for over 30 years in treating rheumatoid arthritis in Asia. The question is, how effective will Bucillamine be in treating COVID-19?
Bucillamine often gets compared to Acetylcysteine (NAC), since it is a more powerful Thiol donor than NAC. It was believed that the anti-inflammatory effect, and general availability, of NAC would make it a good candidate to treat severe cases of COVID-19. That didn’t pan out: https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciaa1443/5910353
By designing the current trial to focus on mild and moderate cases of COVID, Revive does increase their chance of success, as well as the addressable population. It was also recently discovered that Thiol based drugs could disable the spike protein of COVID: https://revivethera.com/wp-content/uploads/2020/12/2020.12.08.415505v1.full_.pdf
That alone is promising, especially since Bucillamine is such a potent Thiol donor. But it is not fully indicative of what will happen. The same way I thought it was really irresponsible for people to start shilling hydroxychloroquine or ivermectin before they could be tested in-vivo. You never know that in-vitro results translate until you see how a drug interacts with everything else in the body.
On that front, we do know that Bucillamine tends to generate glutathione in-vivo: https://pubmed.ncbi.nlm.nih.gov/16806086/
That is also promising since COVID may be causing the biggest issues due to a decrease in endogenous glutathione: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7263077/
Which suggests that Bucillamine could be well positioned to prevent mild or moderate cases from becoming severe. So as a biomedical engineer who does clinical research, I’d say the preliminary data indicates a better than average chance of success. Bucillamine has more going for it than the average repurposed drug, but that doesn’t guarantee its success. Good luck everyone, hang tight for those interim Phase 3 results.
EDIT: The psilocybin program progressed, changing the lowest price I think Revive could go. Also the UK approved two similar rheumatoid arthritis drugs, which increases our likelihood of success, I’ll try to be conservative and estimate about 66% chance of success. https://www.the-scientist.com/news-opinion/uk-approves-arthritis-drugs-for-critically-ill-covid-19-patients-68333
I say the other two drugs are similar, even though the structures are quite different, because tocilizumab, sarilumab, and bucillamine all suppress interleukins (IL) to achieve their anti-inflammatory effect. Tocilizumab and sarilumab, were specifically designed to block IL-6. Bucillamine likely has a broader range of activity, since it calms B cells which “talk” to other cells using interleukins. https://pubmed.ncbi.nlm.nih.gov/8440072/
So now what? Where is Hunter.
With my D!¢k in my mouth, we could see 150$. If you get all the Reddit GME people and say let's f the Big pharma put RVV on the map just maybe we could see 46$. fIVE OR TEN IS A BETTER BET THEN 46$.
4,117 Followers on Twitter. It has been like this for a week.
any news?
what is the Difference between Enrolling by invitation vs Recruiting.
This IS BS Why there taking so long on this. RVV should be the first one to have an oral drug for COVID 19. RVV is getting sodomized by big pharma! If they get 25% BUC might be at 35% to 50%. BUC is a better drug than Colchicine. If they were honest maybe we would be at $46 a share. WTH this is BS. Hope on Monday with this news RVVTF have a run and test $ land. I'm so pissed right now. AND MF SHOULD BE TOO.
https://www.livemint.com/news/world/canadian-study-says-oral-medicine-effective-in-treating-covid19-11611423303706.html
That was his goal when you started. Let hope that is it. If so .10 are coming.
look's like he got his $20 million business.
if that was good news today why did this dog go down?
This dog is going to .10? or it another five years.
It should jump $46! lol Don't know why it's taking this long.
With the news coming out of Japan and the UK. RVVTF should be flying to the 70s today. Even if there is a 35% success rate hoping it's 85%, the FDA should give EUA yesterday.
shroom then .25 next.
WOW, NAC is in phase 4. RVVTF should be $6 stock with the shrooms.
That is BS. Why Az have high COVID19 then.
Where is Hunter!
One year of nothing.
high doses of man-made vitamin D may harm bones.
How long it takes to go through the data! WTH
Yes, it's coming out soon! The key world is Unaware they going to be aware tomorrow.
$ land tomorrow Big PR.
The first orally administered drug to obtain EUA from the FDA next week!! They apply in November for The EUA. Xmas is here run start today to the Dallerland. RVVTF will surpass CYDY end of the year.
BS CYDY is at 6+, and RVVTF is stuck in the penny mud with phase 3. I can't get my head around it.
This would be $2 stock again. Big run to the $ land.
Mind Medicine is a 2.70 they been at .30 four months ago. Why RVVTF is not at a $
Laura Ingraham on FoxNews discussing therapeutic on tonight show Some DR said several drugs and one of them was bucillamine in the end. Then Ingraham interrupts him.
IS BOA taking a stake in RVVTF!